30-7504US tTg-G (FDA cleared)
Intended Use:
The AESKULISA tTg-G is a solid phase enzyme immunoassay for the quantitative and qualitative detection of antibodies against neo-epitopes of tissue transglutaminase (tTG) in human serum.
Recombinant Antigens:
Tissue transglutaminase (neo-epitopes), Cross-linked with specific peptides of gliadin
Native Antigens:
n.a.
Published in
Gastroenterology (FDA cleared Products)
Tagged under
) in the interactive HELIOS picture to activate detailed information regarding the serveral HELIOS features.